Cargando…

Correction to: Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908037/ https://www.ncbi.nlm.nih.gov/pubmed/36383191 http://dx.doi.org/10.1093/ije/dyac222

Ejemplares similares

Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series
por: Chui, Celine S L, et al.
Publicado: (2022)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Correction: Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients
por: Lee, Hee Jeong, et al.
Publicado: (2018)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)

Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study
por: Maret-Ouda, John, et al.
Publicado: (2023)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton pump inhibitors and the risk of pneumonia: a comparison of cohort and self-controlled case series designs
por: Ramsay, Emmae N, et al.
Publicado: (2013)

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
por: Xie, Juntao, et al.
Publicado: (2022)

Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
por: Xie, Juntao, et al.
Publicado: (2022)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: The Light-Driven Proton Pump Proteorhodopsin Enhances Bacterial Survival during Tough Times
por: DeLong, Edward F., et al.
Publicado: (2012)

Correction: A time-series prediction model of acute myocardial infarction in northern of Iran: the risk of climate change and religious mourning
por: Nia, Hamid Sharif, et al.
Publicado: (2022)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)

Correction: Positive Darwinian Selection in the Piston That Powers Proton Pumps in Complex I of the Mitochondria of Pacific Salmon
por: Garvin, Michael R., et al.
Publicado: (2012)

Correction to: Cost–Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low‑Dose Acetylsalicylic Acid Treatment
por: Chau, Sek Hung, et al.
Publicado: (2019)

The Association between Proton Pump Inhibitors and Myocardial Infarction: What Do Food and Drug Administration Data Tell Us?
por: Tan, Jiun Ming, et al.
Publicado: (2019)

Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden
por: Wang, Yun-Han, et al.
Publicado: (2022)

Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study
por: Ikuta, Keiko, et al.
Publicado: (2022)

Correction to: The impact of epicardial adipose tissue in patients with acute myocardial infarction
por: Fisser, Christoph, et al.
Publicado: (2021)

Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry
por: SHI, Wen-Ce, et al.
Publicado: (2020)

Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium
por: Lee, Tsung-Ming, et al.
Publicado: (2018)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

Correction: Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure
por: Glinge, Charlotte, et al.
Publicado: (2020)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Correction: Pro-Inflammatory Action of MIF in Acute Myocardial Infarction via Activation of Peripheral Blood Mononuclear Cells
por: White, David A., et al.
Publicado: (2013)

The selectivity of the Na(+)/K(+)-pump is controlled by binding site protonation and self-correcting occlusion
por: Rui, Huan, et al.
Publicado: (2016)

Correction: Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism
por: Reichert, Karla, et al.
Publicado: (2017)

Correction to: Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction
por: Hao, Xiaojiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eb2jdlo30q3ok0kojc149m5is0